Research on D-chiro-inositol specifically for fertility support is not directly represented in the available evidence, as the single study provided is a registered trial protocol examining myo-inositol — a related but distinct compound — during pregnancy in women with PCOS, with no results yet reported. The MYPP trial is a multicenter, double-blind randomized controlled trial, which represents a rigorous study design, but because it is a protocol rather than a completed study, it contributes no findings to evaluate at this time. Studies indicate that earlier research hinted at potential benefits of myo-inositol for reducing gestational complications in PCOS populations, which motivated this trial, though the evidence base for D-chiro-inositol and fertility outcomes specifically remains outside the scope of what this summary can address from the provided literature. Readers interested in this topic should be aware that the research landscape for inositol compounds and fertility is actively evolving, and conclusions drawn from the available evidence here are substantially limited.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| MYPP trial: Myo-inositol supplementation to prevent pregnancy complications i... | Other | 2025 | Neutral | 90 |